Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New drug combination prevents breast cancer growth pre-surgery

17.05.2005


A new type of drug originally developed for lung cancer can reduce the size of breast cancer tumours when taken in combination with other drugs. A London-based group of scientists, reporting today (Tuesday 17 May) in The Lancet Oncology, say that taking the new drug combination prior to surgery could make breast cancer surgery less invasive and more effective, and reduce the risk of cancer spreading to other parts of the body.



Around 80% of breast cancers depend on the hormone oestrogen to survive, and removing oestrogen from the body is standard treatment for the disease. However, only half of primary breast cancers respond well to this therapy, leading doctors to use more toxic chemotherapy, which causes many side effects. The researchers have found that by combining existing oestrogen-blocking drugs with a new drug called gefitinib that blocks another receptor on the cancer cell surface, tumour growths shrink more rapidly and to a smaller size.

The study followed 56 post-menopausal women who had cancer cells with oestrogen receptors (ER) and epidermal growth factor receptors (EGFR). Half received the oestrogen-blocker anastrozole and the EGFR-blocker gefitinib, the other half received gefitinib and a placebo. Treatment was for 4-6 weeks, prior to surgery to remove the cancer.


Levels of a molecule that indicates cell proliferation, Ki67, were reduced in both groups. Tumour size was reduced substantially in 14 of the 28 patients assigned both anastrozole and gefitinib, and in 12 of 22 assigned gefitinib alone.

"The presence or EGFR seems to be one of the reasons that standard oestrogen-blockers do not always work in ER-positive breast cancers," comments Professor Charles Coombes, head of cancer medicine at Hammersmith Hospitals NHS Trust and Imperial College London. "In women that are resistant to anti-oestrogen therapy, it may provide a ’back door’ mechanism for cancer cell proliferation. Targeting both these receptors seems to increase the effectiveness of treatment."

"The significant reduction in tumour size, combined with minimal side-effects, makes this an exciting prospect for pre-surgery cancer treatment. We are currently designing larger studies to verify this approach."

Simon Wilde | alfa
Further information:
http://www.hhnt.nhs.uk

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>